Related by context. All words. (Click for frequent words.) 79 loss carryforward 78 NOLs 77 loss carryforwards 71 carryforwards 71 NOL carryforwards 62 loss carryovers 62 carryforward 62 credit carryforwards 59 valuation allowance 58 valuation allowances 57 NOL carryforward 57 asset valuation allowance 56 NOL utilization 55 undistributed earnings 55 substantively enacted 55 loss NOL carryforward 55 retroactive reinstatement 55 loss carrybacks 54 LIFO accounting 53 carryback 52 OTTI charges 52 OPEB expense 52 VIOXX Lawsuits 52 marketable securities 52 debt extinguishments 51 adopting SFAS #R 51 Tax Attributes 51 unrealized derivative gains 51 junior subordinated debentures 51 Stendal mill 51 carrybacks 51 accounts receivable securitization 51 Section #/#K 51 Income Taxes 51 nondeductible expenses 50 reasonably estimable 50 OTTI charge 50 No. #R 50 foreign currency remeasurement 50 operatingincome 50 addback 50 c Represents 50 unrealized depreciation 50 LIFO inventory valuation 50 convertible subordinated notes 50 accounts receivable balances 50 taxable income 49 Filtran Microcircuits Inc. 49 actuarially determined 49 SFAS #R 49 exclude noncash 49 unrealized gains 49 unitholder distributions 49 realizability 49 depreciable assets 49 asset monetizations 49 disqualifying dispositions 49 recourse indebtedness 49 Remainco 49 PFIC 49 PGP Acquisition 49 DAC unlock 49 TASE EVGN.TA 49 d Represents 48 loss carryback 48 Unlevered Cash Flow 48 discontinued operations 48 unconsolidated investee 48 hedge ineffectiveness 48 per dilutedshare 48 LIFO adjustment 48 temporary impairments OTTI 48 EURO#.# [002] 48 Lifecomm Joint Venture 48 nondeductible portion 48 Adjusted EBITDA excludes 48 noncash impairments 48 Visa indemnification 48 noncontrolling interest 48 amortization expense 48 stock basedcompensation 48 nonoperating expense 48 accruals 48 currency remeasurement 48 adopted SFAS #R 47 Pro forma adjustments 47 Senior Secured Term 47 postretirement benefit 47 antidilution 47 FAS #R 47 xxvi 47 Vishay stockholders 47 repay indebtedness 47 Revolving Credit Agreement 47 SIFT Rules 47 REIT Exemption 47 revolver borrowings 47 accelerated depreciation 47 Cash Flow Swap 47 #.#per diluted 47 elective deferrals 47 accrual reversal 47 Valhi stockholders 47 amortizable intangible assets 47 indemnification obligations 47 c Relates 47 IRC § 47 unrealized losses 47 FAFLIC 47 SIFT Tax 47 BioGlue ® 47 Asset Retirement Obligation 47 reinsurance recoverables 46 accretion expense 46 MtM gains 46 uncollectible accounts receivable 46 share repurchase authorizations 46 commodity derivative instruments 46 estimated undiscounted 46 establishing valuation allowance 46 condensed consolidated balance sheet 46 Business Combinations 46 #.# perdiluted 46 REIT taxable 46 Specified Investment 46 undistributed profits 46 millioncompared 46 b Relates 46 undrawn revolver 46 inventories revalued 46 convertible notes 46 Interest expense decreased 46 voluntary prepayment 46 QTDP Program 46 unrealized derivative 46 nondividend distribution 46 convertible exchangeable 46 ReHo 46 RAPTIVA R 46 bond indentures 46 SFSB Inc. 46 NOL carryback 46 compensation expense 46 contingently convertible securities 46 postretirement benefits 46 c Calculated 46 intercompany loans 46 intangible assets 46 unvested options 46 Valuation allowance 46 MFB Corp 46 netincome 46 repurchase authorizations 46 temporary impairments 46 MTP Shares 46 CGAAP 46 aftertax 46 goodwill impairment 46 receivables securitization 46 FAS# R 46 pension curtailment 46 Partnered Brands segment 46 unevaluated properties 46 deductible goodwill impairment 46 unrealized gain 46 FSP #-# 46 applied prospectively 46 Surface Specialties acquisition 45 LIFO method 45 FDIC indemnification 45 subordinated debentures 45 intangible assets impairment 45 MtM impacts 45 profitsharing 45 Predecessor Period 45 FASB Interpretation No. 45 intangible impairment 45 Non Controlling Interests 45 antidilutive 45 #.#/diluted share 45 QUALCOMM pro forma 45 Discontinued Operations 45 amortizable 45 Senior Secured Notes 45 postretirement benefit plans 45 undistributed taxable income 45 PFICs 45 Subpart F 45 nonrecurring expenses 45 Pro forma adjusted EBITDA 45 convertible subordinated debentures 45 unrealized gains losses 45 DiaMed acquisition 45 Hardwoods USLP 45 FNLC 45 escheat laws 45 Gaz Métro inc 45 depreciation accretion 45 DJOFL 45 Rosebel royalty 45 b Reflects 45 cash equivalents marketable securities 45 dacetuzumab collaboration 45 Hardwoods LP 45 fiscal# 45 unrealized hedging 45 NETg acquisition 45 infrequently occurring 45 Senior Convertible Notes 45 unrealized appreciation 45 adopting SFAS 45 LIQUIDITY AND 45 impairment charges 45 intersegment transactions 45 Chemicals Segment 45 LIFO inventory 45 escrowed funds 45 remeasurement 45 exchangeable notes 45 EnPro consolidated 45 c Reflects 45 reinstatement premiums 45 outstanding indebtedness 45 Reconciling Items 45 f Reflects 45 reestimates 45 enacted Patient Protection 45 unrealized derivative losses 45 ABL Facility 45 FDIC indemnification asset 45 unfunded accrued 44 receivables securitization facility 44 Senior Subordinated Discount 44 - - Nforecaddie 44 SBIC leverage 44 goodwill impairment charge 44 prepetition liabilities 44 Kereco 44 undistributed net 44 accrual 44 b Represents 44 Stockholder Rights Plan 44 noncurrent liabilities 44 repurchases 44 MEP Joint Venture 44 subordinated convertible notes 44 unrealized derivative gain 44 Cortelco 44 affiliate Evogene Ltd. www.evogene.com 44 noncash goodwill 44 excluding AOCI 44 - - NetMarigot Bay r 44 Private SecuritiesLitigation Reform Act 44 securitized accounts receivable 44 Senior Subordinated PIK Notes 44 aC corporation 44 noninterest expense decreased 44 ATCF 44 TEB adjustment 44 intercompany indebtedness 44 noncurrent assets 44 Panamax Bulk Carrier 44 Cleartel 44 ofapproximately 44 identifiable intangible assets 44 Excluding nonrecurring items 44 ceded reinsurance 44 ninemonths ended 44 capital expenditures 44 Oxandrin 44 LIFO adjustments 44 PMPS brand 44 earnings pershare 44 LIFO reserve 44 ended September# 44 Gosman Estate 44 hedging derivative instruments 44 nonrecurring items 44 OTTI write downs 44 undrawn commitments 44 - Adjusted [016] 44 4Q FY# 44 excluding goodwill impairment 44 acquired intangible assets 44 includible 44 Zero Coupon Convertible Subordinated 44 marketable securities totaled 44 Possible Loan Losses 44 GLJ Report 44 Noninterest Expense Noninterest expense 44 non recurring 44 Crisa acquisition 44 financialstatements 44 TYN 44 securitized receivables 44 SFAS No. 44 intangible impairments 44 pershare 44 pretax goodwill impairment 44 undrawn revolving credit 44 Swap Transactions 44 aftertax charge 44 Equity Investees 44 Qualified Dividends 44 EBDDT 44 depletable 44 Convertible Notes 44 reinsurance commutations 44 redeemable preferred stock 44 Exterran stockholders 44 Private Securities Reform Act 44 AcG 44 - Adjusted [028] 44 Code Sec 44 GSCT program 44 SEC Rule #g# 44 Pro forma Adjusted EBITDA 44 contractual minimums 44 temporary impairment OTTI 44 share repurchase authorization 44 DXL TM antibodies 44 - -Sumi é Art 44 Hedge ineffectiveness 44 NAREIT definition 44 SBIC debentures 44 noncontrolling interests 44 Canbras 44 IBNR reserves 44 unamortized deferred 44 OPANA franchise 44 Including discontinued operations 43 Rosebel Royalty 43 Asset Retirement Obligations 43 endedDecember 43 Variable Interest Entities VIEs 43 EFFECT OF FOREIGN CURRENCY 43 f Represents 43 FAS CAS pension 43 intercompany receivables 43 Harland Acquisition 43 Avenir Trust 43 adjusted EBITDAS 43 Cheneys owed 43 FIFO method 43 THALOMID 43 FRBNY Credit Facility 43 promissory note receivable 43 postretirement benefit obligations 43 CICA Handbook section 43 forwards NOLs 43 Innovis Entities 43 iv GTx 43 items affecting comparability 43 grantor trust 43 Cheniere Partners 43 Income Taxes Allocable 43 Adjusted FIFO EBITDA 43 Stapled Unit 43 liquidating distributions 43 noncash 43 SFAS No.# 43 NTIC consolidated 43 rebased amounts 43 unaccreted discount 43 DAC unlocking 43 SFAS#R 43 ARIF II 43 Noninterest expense decreased 43 LAE reserves 43 earnout payment 43 exchangeable debentures 43 noncash charge 43 consolidated balance sheet 43 applies prospectively 43 - Loss [010] 43 LYONs 43 ADSI reliance 43 nonGAAP 43 Convertible Debt 43 c Excludes 43 SIFTs 43 Contingent Convertible Notes 43 Individual Annuities segment 43 FSP EITF #-#-# [002] 43 LIFO inventory accounting 43 covenant calculations 43 MDS Proteomics 43 asset impairments 43 MA PFFS 43 intercompany eliminations 43 CAPITAL RESOURCES 43 MMCFEPD 43 QSI segment certain 43 loan chargeoffs 43 CompX 43 ITIN filers 43 postemployment benefits 43 Restated Certificate 43 BPE Segment 43 USD#.#m USD#.# per [002] 43 grandfathering provisions 43 nonforfeitable 43 Consolidated EBITDAR 43 Flow Through SIFT 43 unamortized portion 43 Continued Dumping 43 inventory obsolescence 43 involve risks anduncertainties 43 thetransaction 43 nonoperating items 43 franking credits attached 43 Recurring FFO 43 impairment charge 43 income allocable 43 FIFO inventory 43 diluted share 43 Thomas Regout operations 43 - NeDEFENDERS 43 OREO valuation 43 patented Bioral cochleate technology 43 severance accruals 43 retrospectively adjusted 43 Rev. Rul 43 Arana Therapeutics Limited 43 ABL Revolver 43 Senior Unsecured Notes 43 Xantic acquisition 43 Exterran Holdings indirectly 43 retroactive restatement 43 FSAH 43 Managed Basis 43 Nonoperating expense 43 Operational EBITDA 43 Timeshare segment 43 unsecured indebtedness 43 liabilities 43 HLTH Corporation 43 - NET LOSS [008] 43 BioMarin Genzyme LLC 43 cash flows 43 borrowable resources 43 Assumed provision 43 Evercore LP 43 EURO#.# [001] 43 b Excludes 43 PNOI 43 accumulated undistributed 43 Convertible Subordinated Debentures 43 - - Net [007] 43 Offerors Commercial applies 43 FSP EITF #-#-# [001] 43 sale leaseback transaction 43 Promotions.com subsidiary 43 Lasertel subsidiary 42 SemCanada Crude 42 Unizan merger 42 Inc. OTC CDCO 42 Liquid Yield Option 42 consolidated balance sheets 42 Positively impacting 42 imputation credits 42 noncash goodwill impairment 42 millionand 42 -Cruz Echevarria 42 Ps.6 42 theseforward looking 42 Hedging Relationships 42 EPIL II 42 Amounts Unaudited 42 Income Tax Considerations 42 Retirement Obligations 42 Adjusted OIBA 42 Senior Exchangeable Notes 42 intersegment revenues 42 borrowable funds 42 d Reflects 42 Xantic 42 postretirement benefit OPEB 42 Income Tax Expense 42 Shelf Registration 42 - - Income [022] 42 Convertible Senior 42 Canexus LP 42 QSBS 42 Impairment Losses 42 % Convertible Subordinated 42 uncollectable receivables 42 defeased loans 42 proceeds therefrom 42 Symphony GenIsis 42 Merged Entity 42 unallocated corporate 42 LIFO liquidation 42 Kemur 42 Company noncontributory defined 42 Stock Repurchase Plan 42 unamortized discount 42 FAS#R 42 AOCL 42 AJCA 42 unfavorable variances 42 earnouts 42 withholdable payment 42 Paperboard Packaging segment 42 - SegmentPrincess Dina Mired 42 AMF Ultra Short 42 AutoZone repurchased 42 Acquired Entities 42 stockholders equity 42 refinance indebtedness 42 RRSP contribution room 42 discount accretion 42 ratably 42 No. #R Share 42 3Q FY# 42 Parke Bancorp 42 - - Income [002] 42 Non GAAP adjusted EBITDA 42 Senior Subordinated Debentures 42 MDP Transaction 42 doubtful accounts receivable 42 PetroEdge 42 - Adjusted [017] 42 #,#,# #,#,# Inventories [002] 42 CFFO 42 Debt Extinguishment 42 Subordinated Debentures 42 noncash accounting 42 MSR hedging 42 securities laws 42 IAROC 42 NeuCo 42 Novogyne 42 Unitholder distributions 42 Pro forma EBITDA 42 postretirement 42 GAAP 42 unallocated expenses 42 USD#.#m USD#.# per [001] 42 Note Receivable 42 j Includes 42 LIFO inventory decrement 42 taxpayer itemizes deductions 42 millionin 42 VETO HB 42 taxable REIT 42 INOVA Geophysical 42 successfully integrate Legerity 42 - Non GAAP [027] 42 CICA Section 42 balance sheet securitizations 42 undepreciated 42 FFO Measures 42 hardboard siding claims 42 - Ifreshly dug 42 FASB #R 42 Ps.3 42 Tax Expense 42 noncash impairment charge 42 KETRA 42 LIFO inventory adjustments 42 HSR clearance 42 prioryear 42 distributable earnings 42 unsecured subordinated debentures 42 unamortized issuance costs 42 NETAPP INC. CONDENSED CONSOLIDATED 42 Contingent Convertible Senior 42 OPEB liability 42 excludes noncash 42 borrowings 42 UNII Balance Average 42 noncash pretax charge 42 Medical Assistance Percentages 42 expenses totaled Ps 42 Scheme Consideration 42 receivable balances 42 non recourse RISPERDAL 42 nonrecurring 42 - - Net [035] 42 nine monthsended 42 Extraordinary Item 42 CFR § #.# [004] 42 LILO transactions 42 COLI policies 42 Convertible Subordinated Debt 42 Petrofund unitholders 42 Stock Incentive Plan 42 -Edelsberg 42 QSI segment 42 indebtedness incurred 42 SFY #-# 42 suchstatements 42 Company TSX IFP.A 42 Telephone Excise Tax Refund 42 Zero Coupon Convertible Notes 42 goodwill impairments 42 Therics LLC 42 receivable securitization 42 Catastrophe losses 42 continuingoperations 42 underwriting discounts commissions 42 - Loss [006] 42 Zero Coupon Notes 42 LIFO expense 42 SFAS# R 42 adopted CICA Handbook 42 retroactively restated 42 postretirement benefit expense 42 Revolving Credit Facility 42 Adjusted EBITDAX 42 unamortized 42 pro forma EBITDA 42 Excess Cash Flow 42 translation adjustment 42 - INCOME LOSS [001] 42 website www.nyandcompany.com 42 adopted SFAS 42 Internal Revenue Code 42 deductibility 42 mandatorily redeemable preferred 42 ALICO Holdings 42 OSIs 42 share repurchases 42 - - Net [029] 42 PIK Notes 42 Income Tax Withholding 42 nonconvertible debt 42 Brooks Eckerd acquisition 42 Student Loan Interest Deduction 42 CTVgm 42 Immtech clinical trials 42 Filtertek 42 Drivetrain segment 42 - - Non GAAP [007] 42 Airesurf 42 Common Stock 42 non gaap 42 normalized FFO guidance 42 FHLB borrowings 42 EGTRRA 42 diluted weighted 42 Unleveraged IRR 42 MFFO 42 Marbob acquisition 42 operating income1 42 PrivateSecurities Litigation Reform Act 42 Equity Incentive Plan 42 buyback authorizations 42 Oxy ER 42 APB# 42 Solectron pro forma 42 dilutive effect 42 PWOD 41 Convertible Subordinated Notes 41 Biolevier loan 41 depreciation depletion amortization 41 reinsurance recoveries 41 farmstead exclusion 41 - - [054] 41 FSP APB #-# 41 CAD#m [002] 41 repurchase authorization 41 Discontinued Operation 41 - - Net [033] 41 Exchangeable Senior 41 EBIAT 41 NYSE MIM MID 41 senior unsecured debentures 41 normalized FFO 41 FBAR reporting 41 Corus Aluminum 41 aggregate liquidation preference 41 DSUs 41 nonpension retirement benefits 41 netsales 41 Funded Debt 41 USD#.#m USD#.# [002] 41 lump sum distributions 41 Adjusted Earnings 41 USD#.#m USD#.# [001] 41 Reports Wider 41 Scantron segment decreased 41 Non Controlling Interest 41 discontinued operations - 41 - Loss [019] 41 FSP FAS #-# 41 accretion DD & 41 adjusted EBITDAR 41 SFAS# 41 Interest Expense Interest expense 41 calculating FFO 41 Subordinated Convertible Notes 41 USPoly 41 - Income [006] 41 Deferred Income Tax 41 adjusted distributable cash 41 unaccreted 41 European Windstorm Xynthia 41 fully diluted 41 FAS #R Share 41 - - Income [015] 41 SFAS 41 = Adjusted [004] 41 Qualcomm Strategic Initiatives 41 ASC #-# 41 nondeductible 41 Polymer Additives segment 41 QSPE 41 Senior Subordinated 41 Repurchase Program 41 EBIT amounted 41 GVIC consolidated debt 41 Senior Notes 41 OPEB obligation 41 B Preferred Stock 41 enhanced FMAP 41 Currency translation 41 Teekay Offshore Teekay LNG 41 accretable yield 41 STECO acquisition 41 asset impairment 41 Core FFO 41 intercompany balances 41 carryback provision 41 Visa MasterCard antitrust 41 Unfunded pension 41 nonroutine income 41 mandatorily redeemable 41 DNOI 41 reasonably determinable 41 FSAH acquisition 41 Ps.2 41 Significant Items 41 Iusacell Celular 41 - Non GAAP [001] 41 HNTE 41 Synthetic Fuel 41 - - Income [006] 41 Appreciation Rights 41 income teb 41 EBDT 41 differmaterially 41 Profile Research AMXL.MX Quote 41 underwriters overallotment option 41 EUR #,# Mio 41 -DD2 41 = Basic [015] 41 deducting underwriting commissions 41 American Jobs Creation 41 Existing Debentures 41 unconsolidated investees 41 apportionment formula 41 Term Facility 41 footnotes thereto 41 deductible IRAs 41 excludes unrealized gains 41 Items excluded 41 Vacation Interval sales 41 balance sheet deleveraging 41 PDP MLR 41 Therics 41 capitalizable 41 unconsolidated affiliate 41 unabsorbed fixed overhead 41 #,#,# #,#,# Deferred [001] 41 ELIOKEM 41 distort comparability 41 - - Income [021] 41 Comparable EBITDA 41 - CASH FLOWS [012] 41 - Adjusted [022] 41 Reclassifications 41 adopting IFRS 41 consolidated VIE 41 Contingent Value Right 41 Adjusted EBIDTA 41 Optim Energy 41 Scantron segment increased 41 adjusted OIBDA margin 41 cash equivalents 41 goodwill intangible 41 depletion depreciation 41 CICA Accounting Guideline 41 Unusual Items section 41 Accounting Guideline 41 Commodity Margin 41 AOCI 41 Secured Facility 41 BlackRock LTIP shares 41 - - Net [047] 41 - Weighted average [004] 41 undrawn revolving 41 Subordinated Notes Due 41 website wglholdings.com 41 Copano commodity 41 - Adjusted [025] 41 amortized cost 41 Susquehanna Bancshares Inc 41 Real Estate Owned OREO 41 refranchising transactions 41 Income Tax Provision 41 c Consists 41 ceding commissions 41 CASH FLOWS PROVIDED BY 41 Lagunas Norte Pierina 41 accelerated vesting 41 TEPPCO GP 41 Current Repurchase Program 41 policyholder dividends 41 principal paydowns 41 QMLP 41 unbooked resource potential 41 unamortized financing 41 synfuel 41 Private Securities Litigation ReformAct 41 anduncertainties 41 Jiantou Xinyuan 41 MNOK #.# 41 months endedSeptember 41 asset impairments restructuring 41 Hedging Relationships AcG 41 FIGA assessment 41 Stock Repurchase Program 41 toreflect 41 BY RICHARD RYMAN 41 modestly accretive 41 AMFM Notes 41 consents authorizations 41 - Income [003] 41 defease 41 LibertyBank Acquisition 41 Annual Incentive Plan 41 SunPower incurs amortization 41 pretax noncash 41 Payment FAS #R 41 Astaris joint venture 41 early extinguishments 41 BGSS 41 Adjusted EBIT 41 commonstock 41 Convertible Promissory Notes 41 noncash amortization 41 TSX EIT.UN 41 Revolving Facility 41 - Adjusted [030] 41 Excluding goodwill impairment 41 INCOME TAXES 41 - EBITDA [003] 41 phytosterol revenues 41 Hesperion acquisition 41 senior subordinated convertible 41 GMDB 41 LIFO inventory reserve 41 No. #R SFAS 41 unescalated 41 Normalized EPS 41 - -Guldeniz 41 Medicare Advantage PFFS 41 CEFF financings subject 41 undepreciated assets 41 filingswith 41 Discontinued operations 41 nonoperating income 41 -worht 41 valuation adjustments 41 visit www.bioject.com 41 Unusual Items 41 FASB ASC 41 accretable 41 ROACE 41 fiscalyear 41 AGY Asia 41 MZT Holdings 41 depreciable asset 41 OPEB 40 EPE unitholders 40 Stockholder Equity 40 risks anduncertainties 40 TOBs 40 FIN #R 40 Biolevier loan facility 40 Consolidated Adjusted EBITDA 40 Schlumberger GCS 40 v Dot VN 40 Normalized EBITDA 40 UBTI 40 = Basic [035] 40 USOGP 40 indebtedness 40 Gross Addition CPGA 40 RCOP 40 SFAS #R Share 40 EITF #-# [001] 40 Debt extinguishments 40 NMHG Retail 40 Unilin segment 40 - - Net [052] 40 Acquisition Transaction 40 RMB #,#.# 40 Provident Upstream 40 Other Income Expense 40 involve risksand uncertainties 40 subordinated indebtedness 40 - - Net [051] 40 Standardized Measure 40 Contingent consideration 40 nonoperating expenses 40 accelerated filer 40 - - Net [034] 40 unaudited consolidated balance sheets 40 QCRH 40 Adjusted EBTIDA 40 Explores Strategic Alternatives 40 Successor Period 40 -By Cliodhna McGowan 40 unredeemed gift cards 40 contingently issuable 40 unrealized 40 - LossSanta Margarita Ranch 40 revolving credit 40 equity accounted investees 40 Domilens 40 Barrett NDEx 40 FSAH Acquisition 40 - - Loss [008] 40 identifiable intangibles 40 - Non GAAP [031] 40 EMEA Subsidiaries 40 historicalfacts 40 SEK -#.# -#.# [003] 40 - LTEAMMATES 40 Provision Benefit 40 NYSE EXH indirectly 40 Wireline segment 40 Restated Declaration 40 Teksid Luxembourg 40 Existing Warrants 40 barrels MMBbls 40 forward lookinginformation 40 Ps.7 40 - Net [011] 40 intercompany 40 Legislation Reform Act 40 EnerCare 40 Discovery Project QTDP 40 #compared 40 equity method investees 40 Exchangeable Units 40 - - Net [023] 40 Notes LYONs 40 NEYYF 40 Earnout 40 solvency deficiency 40 nonaccrual loan 40 regarding Heska 40 risksand uncertainties 40 Senior Secured Convertible Notes 40 dollar denominated debenture 40 impacting comparability 40 Pro Forma EBITDA 40 undiscounted cash 40 earnout payments 40 - Non GAAP [009] 40 dividends thereon 40 NYSE APL 40 USC #a [002] 40 Accelerated Share Repurchase 40 calculates FFO 40 Incurred losses 40 Tecstar Automotive Group 40 IBNR reserve 40 intercompany transactions 40 file Form #X 40 intangibles impairment 40 #,# -BOB SANSEVERE 40 - - [085] 40 - Loss [017] 40 Shurgard Europe 40 forward.looking statements 40 g Represents 40 investees partially offset 40 affecting comparability 40 derivative instruments 40 pro forma adjusted EBITDA 40 calculating distributable cash 40 accreted value 40 CDSOA 40 CICA Handbook 40 quarter offiscal 40 ONEOK Partners segment 40 Neurogen stockholders 40 EXLP 40 tarmac strandings Hanni 40 Omnibus Incentive Plan 40 - - Income [031] 40 Liquor Stores LP 40 = Adjusted [002] 40 amortize goodwill